Circulating Tumor Cells and Circulating Tumor DNA
Tóm tắt
Solid tumors derived from epithelial tissues (carcinomas) are responsible for 90% of all new cancers in Europe, and the main four tumor entities are breast, prostate, lung, and colon cancer. Present tumor staging is mainly based on local tumor extension, metastatic lymph node involvement, and evidence of overt distant metastasis obtained by imaging technologies. However, these staging procedures are not sensitive enough to detect early tumor cell dissemination as a key event in tumor progression. Many teams have therefore focused on the development of sensitive assays that allow the specific detection of single tumor cells or small amounts of cell-free tumor DNA in the peripheral blood of cancer patients. These methods allow the detection and characterization of early metastatic spread and will provide unique insights into the biology of metastatic progression of human tumors, including the effects of therapeutic interventions.
Từ khóa
Tài liệu tham khảo
17. Andreopoulou E, Yang LY, Rangel KM, et al. 2011. Comparison of assay methods for detection of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex CellSearch system.Int. J. Cancer.Epub ahead of print
32. Mego M, Mani SA, Lee BN, et al. 2011. Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: the effect of neoadjuvant therapy.Int. J. Cancer.Epub ahead of print
Agrawal B, 1998, Cancer Res., 58, 4079
74. National Cancer Institute. 2011. Treatment decision making based on blood levels of tumor cells in women with metastatic breast cancer receiving chemotherapy. SWOG-S0500.http://clinicaltrials.gov/ct2/show/NCT00382018
Braun S, 2001, Cancer Res., 61, 1890